Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: A systematic review for the Lives Saved Tool

BMC Public Health

Volumn 11, Issue SUPPL. 3, 2011, Pages

  Thwing, Julie ^a   Eisele, Thomas P ^b   Steketee, Richard W ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b TULANE UNIVERSITY   (United States)

^c Malaria Control and Evaluation Partnership in Africa (MACEPA)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; QUININE;

AFRICA SOUTH OF THE SAHARA; CASE MANAGEMENT; CHILD; CHILDHOOD MORTALITY; DRUG COMBINATION; HUMAN; MALARIA FALCIPARUM; META ANALYSIS; MORTALITY; REVIEW; TREATMENT OUTCOME;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; CASE MANAGEMENT; CHILD; CHILD MORTALITY; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; QUININE; TREATMENT OUTCOME;

EID: 79954528947     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-S3-S14     Document Type: Review

References (84)

1. A world malaria map: Plasmodium falciparum endemicity in 2007. SI Hay CA Guerra PW Gething AP Patil AJ Tatem AM Noor CW Kabaria BH Manh IR Elyazar S Brooker,, et al. PLoS Med 2009 6 3 1000048 10.1371/journal.pmed.1000048 19323591
2. World Malaria Report 2008. WHO, Geneva: WHO, WHO, 2008
3. Artemisinin-based combination therapy for treating uncomplicated malaria. D Sinclair B Zani S Donegan P Olliaro P Garner, Cochrane database of systematic reviews (Online) 2009 3 D007483 19588433
4. Artesunate combinations for treatment of malaria: meta-analysis. M Adjuik A Babiker P Garner P Olliaro W Taylor N White, Lancet 2004 363 9402 9 17 10.1016/S0140-6736(03)15162-8 14723987 (Pubitemid 38076919)
5. World Malaria Report 2009. WHO, Geneva: WHO, WHO, 2009
6. Artemisinin derivatives for treating severe malaria. HM McIntosh P Olliaro, Cochrane database of systematic reviews (Online) 2000 2 D000527 10796551
7. The management of patients with severe malaria. N Day AM Dondorp, The American journal of tropical medicine and hygiene 2007 77 6 Suppl 29 35 18165472
8. Rectal administration of artemisinin derivatives for the treatment of malaria. HA Karunajeewa L Manning I Mueller KF Ilett TM Davis, JAMA 2007 297 21 2381 2390 10.1001/jama.297.21.2381 17551131 (Pubitemid 46883751)
9. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. AM Dondorp CI Fanello IC Hendriksen E Gomes A Seni KD Chhaganlal K Bojang R Olaosebikan N Anunobi K Maitland,, et al. Lancet 2010 376 9753 1647 1657 10.1016/S0140- 6736(10)61924-1 21062666
10. How many child deaths can we prevent this year? G Jones RW Steketee RE Black ZA Bhutta SS Morris, Lancet 2003 362 9377 65 71 10.1016/S0140-6736(03) 13811-1 12853204 (Pubitemid 36835825)
11. Standards for CHERG reviews of intervention effects on child survival. N Walker C Fischer-Walker J Bryce R Bahl S Cousens, Int J Epidemiol 2010 39 Suppl 1 21 31 10.1093/ije/dyq036 20348122
12. Grading quality of evidence and strength of recommendations. D Atkins D Best PA Briss M Eccles Y Falck-Ytter S Flottorp GH Guyatt RT Harbour MC Haugh D Henry,, et al. Bmj 2004 328 7454 1490 10.1136/bmj.328.7454.1490 15205295
13. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. JR Zucker, Emerg Infect Dis 1996 2 1 37 43 10.3201/eid0201.960104 8964058 (Pubitemid 126444965)
14. Delphi survey of malaria mortality and drug resistance in Africa. P Sudre JG Breman JP Koplan, Lancet 1990 335 8691 722 10.1016/0140-6736(90)90833-Q 1969074 (Pubitemid 20089331)
15. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. GO Adjei JA Kurtzhals OP Rodrigues M Alifrangis LC Hoegberg ED Kitcher EV Badoe R Lamptey BQ Goka, Malaria journal 2008 7 127 10.1186/1475-2875-7-127 18620577
16. Randomized, controlled dose-optimization studies of dihydroartemisinin- piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. EA Ashley S Krudsood L Phaiphun S Srivilairit R McGready W Leowattana R Hutagalung P Wilairatana A Brockman S Looareesuwan,, et al. The Journal of infectious diseases 2004 190 10 1773 1782 10.1086/425015 15499533 (Pubitemid 39487822)
17. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. EA Ashley R McGready R Hutagalung L Phaiphun T Slight S Proux KL Thwai M Barends S Looareesuwan NJ White,, et al. Clin Infect Dis 2005 41 4 425 432 10.1086/432011 16028147 (Pubitemid 41099632)
18. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. EA Ashley KM Lwin R McGready WH Simon L Phaiphun S Proux N Wangseang W Taylor K Stepniewska W Nawamaneerat,, et al. Trop Med Int Health 2006 11 11 1653 1660 10.1111/j.1365-3156.2006.01724. x 17054744 (Pubitemid 44624367)
19. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore. M Bonnet C Roper M Felix L Coulibaly GM Kankolongo JP Guthmann, Malaria journal 2007 6 54 10.1186/1475-2875-6-54 17477865
20. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. JT Bousema P Schneider LC Gouagna CJ Drakeley A Tostmann R Houben JI Githure R Ord CJ Sutherland SA Omar,, et al. The Journal of infectious diseases 2006 193 8 1151 1159 10.1086/503051 16544256
21. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. H Bukirwa A Yeka MR Kamya A Talisuna K Banek N Bakyaita JB Rwakimari PJ Rosenthal F Wabwire-Mangen G Dorsey,, et al. PLoS Clin Trials 2006 1 1 7 10.1371/journal.pctr.0010007 16871329
22. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. AA Djimde B Fofana I Sagara B Sidibe S Toure D Dembele S Dama D Ouologuem A Dicko OK Doumbo, The American journal of tropical medicine and hygiene 2008 78 3 455 461 18337343 (Pubitemid 351845197)
23. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. G Dorsey S Staedke TD Clark D Njama-Meya B Nzarubara C Maiteki-Sebuguzi C Dokomajilar MR Kamya PJ Rosenthal, JAMA 2007 297 20 2210 2219 10.1001/jama.297.20.2210 17519410
24. High efficacy of two artemisinin-based combinations (artemether- lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. CO Falade AO Ogundele BO Yusuf OG Ademowo SM Ladipo, Trop Med Int Health 2008 13 5 635 643 10.1111/j.1365-3156.2008.02043.x 18346028 (Pubitemid 351561605)
25. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. CI Fanello C Karema W van Doren C Van Overmeir D Ngamije U D'Alessandro, Trans R Soc Trop Med Hyg 2007 101 4 344 350 10.1016/j.trstmh.2006.06.010 17005222 (Pubitemid 46196260)
26. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. B Faye JL Ndiaye D Ndiaye Y Dieng O Faye O Gaye, Malaria journal 2007 6 80 10.1186/1475-2875-6-80 17570848
27. A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. T Grande A Bernasconi A Erhart D Gamboa M Casapia C Delgado K Torres C Fanello A Llanos-Cuentas U D'Alessandro, PLoS ONE 2007 2 10 1101 10.1371/journal.pone.0001101 17971864
28. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine- pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. JP Guthmann J Ampuero F Fortes C van Overmeir V Gaboulaud S Tobback J Dunand N Saraiva P Gillet J Franco,, et al. Trans R Soc Trop Med Hyg 2005 99 7 485 492 15876443 (Pubitemid 40692060)
29. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. JP Guthmann S Cohuet C Rigutto F Fortes N Saraiva J Kiguli J Kyomuhendo M Francis F Noel M Mulemba,, et al. The American journal of tropical medicine and hygiene 2006 75 1 143 145 16837721 (Pubitemid 351627583)
30. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. S Hamour Y Melaku K Keus J Wambugu S Atkin J Montgomery N Ford C Hook F Checchi, Trans R Soc Trop Med Hyg 2005 99 7 548 554 10.1016/j.trstmh.2004.10.003 15869770 (Pubitemid 40692069)
31. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. AR Hasugian HL Purba E Kenangalem RM Wuwung EP Ebsworth R Maristela PM Penttinen F Laihad NM Anstey E Tjitra,, et al. Clin Infect Dis 2007 44 8 1067 1074 10.1086/512677 17366451 (Pubitemid 46580274)
32. A randomized trial of artemether-lumefantrine versus mefloquine- artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. R Hutagalung L Paiphun EA Ashley R McGready A Brockman KL Thwai P Singhasivanon T Jelinek NJ White FH Nosten, Malaria journal 2005 4 46 10.1186/1475-2875-4-46 16179089
33. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. B Janssens M van Herp L Goubert S Chan S Uong S Nong D Socheat A Brockman EA Ashley W Van Damme, Trop Med Int Health 2007 12 2 251 259 10.1111/j.1365-3156.2006.01786.x 17300633
34. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. MR Kamya A Yeka H Bukirwa M Lugemwa JB Rwakimari SG Staedke AO Talisuna B Greenhouse F Nosten PJ Rosenthal,, et al. PLoS Clin Trials 2007 2 5 20 10.1371/journal.pctr.0020020 17525792
35. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. C Karema CI Fanello C van Overmeir JP van Geertruyden W van Doren D Ngamije U D'Alessandro, Trans R Soc Trop Med Hyg 2006 100 12 1105 1111 10.1016/j.trstmh.2006.01.001 16766006 (Pubitemid 44464010)
36. A trial of combination antimalarial therapies in children from Papua New Guinea. HA Karunajeewa I Mueller M Senn E Lin I Law PS Gomorrai O Oa S Griffin K Kotab P Suano,, et al. The New England journal of medicine 2008 359 24 2545 2557 10.1056/NEJMoa0804915 19064624
37. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali. K Kayentao H Maiga RD Newman ML McMorrow A Hoppe O Yattara H Traore Y Kone EA Guirou R Saye,, et al. Malaria journal 2009 8 5 10.1186/1475-2875-8-5 19128455
38. A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. R Kobbe P Klein S Adjei S Amemasor WN Thompson H Heidemann MV Nielsen J Vohwinkel B Hogan B Kreuels,, et al. Malaria journal 2008 7 261 10.1186/1475-2875-7-261 19099594
39. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. KA Koram B Abuaku N Duah N Quashie, Acta tropica 2005 95 3 194 203 10.1016/j.actatropica.2005.06.018 16054584 (Pubitemid 41207282)
40. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefevre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, The American journal of tropical medicine and hygiene 2001 64 5-6 247 256 11463111
41. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. A Martensson J Stromberg C Sisowath MI Msellem JP Gil SM Montgomery P Olliaro AS Ali A Bjorkman, Clin Infect Dis 2005 41 8 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
42. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. M Mayxay M Khanthavong N Lindegardh S Keola M Barends T Pongvongsa R Yapom A Annerberg S Phompida R Phetsouvanh,, et al. Clin Infect Dis 2004 39 8 1139 1147 10.1086/424512 15486837 (Pubitemid 40169311)
43. Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. D Menard NN Andrianina Z Ramiandrasoa A Randriamanantena N Rasoarilalao M Jahevitra A Ratsimbasoa L Tuseo A Raveloson, Malaria journal 2007 6 65 10.1186/1475-2875-6- 65 17519010
44. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. PF Mens P Sawa SM van Amsterdam I Versteeg SA Omar HD Schallig PA Kager, Malaria journal 2008 7 237 10.1186/1475-2875-7-237 19017387
45. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan. EA Mukhtar NB Gadalla SE El-Zaki I Mukhtar FA Mansour A Babiker BB El-Sayed, Malaria journal 2007 6 92 10.1186/1475-2875-6-92 17631681
46. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 9469 1474 1480 10.1016/S0140-6736(05)66417-3 15850631 (Pubitemid 40591692)
47. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. S Owusu-Agyei KP Asante R Owusu M Adjuik S Amenga-Etego DK Dosoo J Gyapong B Greenwood D Chandramohan, PLoS ONE 2008 3 6 2530 10.1371/journal.pone.0002530 18575626
48. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. A Ratcliff H Siswantoro E Kenangalem R Maristela RM Wuwung F Laihad EP Ebsworth NM Anstey E Tjitra RN Price, Lancet 2007 369 9563 757 765 10.1016/S0140-6736(07) 60160-3 17336652 (Pubitemid 46335820)
49. A randomized trial of artesunate-mefloquine versus artemether- lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. I Sagara A Diallo M Kone M Coulibaly SI Diawara O Guindo H Maiga MB Niambele M Sissoko A Dicko,, et al. The American journal of tropical medicine and hygiene 2008 79 5 655 661 18981499
50. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. F Smithuis MK Kyaw O Phe KZ Aye L Htet M Barends N Lindegardh T Singtoroj E Ashley S Lwin,, et al. Lancet 2006 367 9528 2075 2085 10.1016/S0140-6736(06)68931-9 16798391 (Pubitemid 43949291)
51. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. SG Staedke A Mpimbaza MR Kamya BK Nzarubara G Dorsey PJ Rosenthal, Lancet 2004 364 9449 1950 1957 10.1016/S0140-6736(04) 17478-3 15567011 (Pubitemid 39574598)
52. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. JM Stohrer S Dittrich V Thongpaseuth V Vanisaveth R Phetsouvanh S Phompida F Monti EM Christophel N Lindegardh A Annerberg,, et al. Trop Med Int Health 2004 9 11 1175 1183 10.1111/j.1365-3156. 2004.01320.x 15548313 (Pubitemid 39573989)
53. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. TD Swarthout IV van den Broek G Kayembe J Montgomery H Pota C Roper, Trop Med Int Health 2006 11 10 1503 1511 10.1111/j.1365-3156.2006.01710.x 17002724 (Pubitemid 44450555)
54. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. N Tangpukdee S Krudsood W Thanachartwet K Chalermrut C Pengruksa S Srivilairit U Silachamroon P Wilairatana S Phongtananant S Kano,, et al. The Southeast Asian journal of tropical medicine and public health 2005 36 5 1085 1091 16438129 (Pubitemid 43058822)
55. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. TH Tran C Dolecek PM Pham TD Nguyen TT Nguyen HT Le TH Dong TT Tran K Stepniewska NJ White,, et al. Lancet 2004 363 9402 18 22 10.1016/S0140-6736(03)15163-X 14723988 (Pubitemid 38076920)
56. Efficacy of chloroquine + sulfadoxine - pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. IV van den Broek UA Maung A Peters L Liem M Kamal M Rahman MR Rahman AM Bangali S Das M Barends,, et al. Trans R Soc Trop Med Hyg 2005 99 10 727 735 10.1016/j.trstmh.2005.02.007 16095643 (Pubitemid 41150668)
57. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. I van den Broek C Kitz S Al Attas F Libama M Balasegaram JP Guthmann, Malaria journal 2006 5 113 10.1186/1475-2875-5-113 17125496
58. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. M van Vugt S Looareesuwan P Wilairatana R McGready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 5 545 548 10.1016/S0035-9203(00)90082-8 11132386
59. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. A Yeka K Banek N Bakyaita SG Staedke MR Kamya A Talisuna F Kironde SL Nsobya A Kilian M Slater,, et al. PLoS Med 2005 2 7 190 10.1371/journal.pmed.0020190 16033307
60. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. A Yeka G Dorsey MR Kamya A Talisuna M Lugemwa JB Rwakimari SG Staedke PJ Rosenthal F Wabwire-Mangen H Bukirwa, PLoS ONE 2008 3 6 2390 10.1371/journal.pone.0002390 18545692
61. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. I Zongo G Dorsey N Rouamba H Tinto C Dokomajilar RT Guiguemde PJ Rosenthal JB Ouedraogo, Lancet 2007 369 9560 491 498 10.1016/S0140-6736(07)60236-0 17292769 (Pubitemid 46223467)
62. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. I Zongo G Dorsey N Rouamba C Dokomajilar Y Sere PJ Rosenthal JB Ouedraogo, Clin Infect Dis 2007 45 11 1453 1461 10.1086/522985 17990228 (Pubitemid 351411875)
63. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). M Mayxay V Thongpraseuth M Khanthavong N Lindegardh M Barends S Keola T Pongvongsa S Phompida R Phetsouvanh K Stepniewska,, et al. Trop Med Int Health 2006 11 8 1157 1165 10.1111/j.1365-3156.2006.01671.x 16903879 (Pubitemid 44125705)
64. Severe malaria in children in Togo. JK Assimadi AD Gbadoe DY Atakouma K Agbenowossi K Lawson-Evi A Gayibor Y Kassankogno, Arch Pediatr 1998 5 12 1310 1315 10.1016/S0929-693X(99)80048-7 9885736
65. Malaria in rural Mozambique. Part II: children admitted to hospital. Q Bassat C Guinovart B Sigauque P Aide J Sacarlal T Nhampossa A Bardaji A Nhacolo E Macete I Mandomando,, et al. Malaria journal 2008 7 37 10.1186/1475-2875-7-37 18302771
66. The causes of hospital admission and death among children in Bamako, Mali. JD Campbell SO Sow MM Levine KL Kotloff, Journal of tropical pediatrics 2004 50 3 158 163 10.1093/tropej/50.3.158 15233192 (Pubitemid 38807835)
67. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. AE Greenberg M Ntumbanzondo N Ntula L Mawa J Howell F Davachi, Bull World Health Organ 1989 67 2 189 196 2743538 (Pubitemid 19160708)
68. Differences in presentation of severe malaria in urban and rural Gabon. S Issifou E Kendjo MA Missinou PB Matsiegui A Dzeing-Ella FA Dissanami M Kombila S Krishna PG Kremsner, The American journal of tropical medicine and hygiene 2007 77 6 1015 1019 18165514 (Pubitemid 351837785)
69. Indicators of life-threatening malaria in African children. K Marsh D Forster C Waruiru I Mwangi M Winstanley V Marsh C Newton P Winstanley P Warn N Peshu,, et al. The New England journal of medicine 1995 332 21 1399 1404 10.1056/NEJM199505253322102 7723795
70. Manifestation and outcome of severe malaria in children in northern Ghana. FP Mockenhaupt S Ehrhardt J Burkhardt SY Bosomtwe S Laryea SD Anemana RN Otchwemah JP Cramer E Dietz S Gellert,, et al. The American journal of tropical medicine and hygiene 2004 71 2 167 172 15306705 (Pubitemid 39108825)
71. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. D Schellenberg C Menendez E Kahigwa F Font C Galindo C Acosta JA Schellenberg JJ Aponte J Kimario H Urassa,, et al. The American journal of tropical medicine and hygiene 1999 61 3 431 438 10497986 (Pubitemid 29428716)
72. Clinical features and outcome of severe malaria in Gambian children. D Waller S Krishna J Crawley K Miller F Nosten D Chapman FO ter Kuile C Craddock C Berry PA Holloway,, et al. Clin Infect Dis 1995 21 3 577 587 10.1093/clinids/21.3.577 8527547
73. In-hospital risk estimation in children with malaria - early predictors of morbidity and mortality. AS Winkler G Salmhofer R Helbok F Kalokola W Matuja E Schmutzhard, Journal of tropical pediatrics 2008 54 3 184 191 10.1093/tropej/fmm108 18211951 (Pubitemid 351827464)
74. Malaria. Principles of prevention and treatment. JR Zucker CC Campbell, Infect Dis Clin North Am 1993 7 3 547 567 8254159
75. Anaemia, blood transfusion practices, HIV and mortality among women of reproductive age in western Kenya. JR Zucker EM Lackritz TK Ruebush AW Hightower JE Adungosi JB Were CC Campbell, Trans R Soc Trop Med Hyg 1994 88 2 173 176 10.1016/0035-9203(94)90283-6 8036663 (Pubitemid 24139677)
76. Reduced in-hospital mortality after improved management of children under 5 years admitted to hospital with malaria: randomised trial. S Biai A Rodrigues M Gomes I Ribeiro M Sodemann F Alves P Aaby, BMJ 2007 335 7625 862 10.1136/bmj.39345.467813.80 17954513
77. Manifestations, quality of emergency care and outcome of severe malaria in Mulago Hospital, Uganda. R Idro J Aloyo, Afr Health Sci 2004 4 1 50 57 15126192
78. Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. AR Oduro KA Koram W Rogers F Atuguba P Ansah T Anyorigiya A Ansah F Anto N Mensah A Hodgson,, et al. Malaria journal 2007 6 96 10.1186/1475-2875-6-96 17662142
79. Life-threatening malaria in African children: a prospective study in a mesoendemic urban setting. S Ranque B Poudiougou A Traore M Keita AA Oumar I Safeukui S Marquet S Cabantous M Diakite D Mintha,, et al. Pediatr Infect Dis J 2008 27 2 130 135 18174865
80. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. H Reyburn R Mbatia C Drakeley J Bruce I Carneiro R Olomi J Cox WM Nkya M Lemnge BM Greenwood,, et al. JAMA 2005 293 12 1461 1470 10.1001/jama.293.12.1461 15784869 (Pubitemid 40393290)
81. The public health impact of chloroquine resistance in Africa. JF Trape, The American journal of tropical medicine and hygiene 2001 64 1-2 Suppl 12 17 11425173
82. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. JR Zucker TK Ruebush 2nd C Obonyo J Otieno CC Campbell, The American journal of tropical medicine and hygiene 2003 68 4 386 390 12879851 (Pubitemid 38230635)
83. Malaria treatment in remote areas of Mali: use of modern and traditional medicines, patient outcome. D Diallo B Graz J Falquet AK Traore S Giani PP Mounkoro A Berthe M Sacko C Diakite, Trans R Soc Trop Med Hyg 2006 100 6 515 520 10.1016/j.trstmh.2005.08.003 16233907
84. Guidelines for Core Population-based Indicators. RBM, Maryland: Roll Back Malaria, MEASURE Evaluation, World Health Organization, UNICEF 2008